STOCK TITAN

AGILE THERAPEUTICS INC - $AGRX STOCK NEWS

Welcome to our dedicated page for AGILE THERAPEUTICS news (Ticker: $AGRX), a resource for investors and traders seeking the latest updates and insights on AGILE THERAPEUTICS stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect AGILE THERAPEUTICS's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of AGILE THERAPEUTICS's position in the market.

Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.71%
Tags
-
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.8%
Tags
conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.98%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.73%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.05%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.14%
Tags
conferences
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.14%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.79%
Tags
conferences earnings
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.05%
Tags
none
AGILE THERAPEUTICS INC

Nasdaq:AGRX

AGRX Rankings

AGRX Stock Data

2.64M
6.85M
0.42%
3.71%
7.49%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States of America
Princeton

About AGRX

agile therapeutics is a forward-thinking women's healthcare company dedicated to fulfilling the unmet health needs of today's women. our product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method. our lead product candidate, twirla®, (ethinyl estradiol and levonorgestrel transdermal system), also known as ag200-15, is a once-weekly prescription contraceptive patch that recently completed phase 3 trials. twirla is based on our proprietary transdermal patch technology, called skinfusion®, which is designed to provide advantages over currently available patches and is intended to optimize patch adhesion and patient wearability. for more information, please visit the company website at www.agiletherapeutics.com. connect with us on twitter at @agilether.